BUKWANG PHARMACEUTICAL IND CO.,LTD

R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.

003000 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 동작구 대방동1길 47, 서울특별시
Website:: https://www.bukwang.co.kr/en/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bukwang Pharmaceutical Co., Ltd. is an R&D-focused pharmaceutical company engaged in the development, manufacturing, and commercialization of therapeutic drugs. The company employs an 'open innovation' strategy, utilizing strategic investments, joint ventures, research collaborations, and acquisitions to expand its drug pipeline and enhance its global competitiveness. Its development pipeline targets a range of conditions, with a focus on central nervous system (CNS) disorders such as schizophrenia (Lurasidone) and Parkinson's disease (JM-010), as well as oncology (SOL-804 for prostate cancer), liver diseases, and metabolic disorders. Through continuous research and strategic partnerships, Bukwang aims to become a global pharmaceutical innovator.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BUKWANG PHARMACEUTICAL IND CO.,LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-08-29 00:00	Related Party Transaction 대규모기업집단현황공시[분기별공시(개별회사용)]	Korean	10.5 KB

Automate Your Workflow. Get a real-time feed of all BUKWANG PHARMACEUTICAL IND CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BUKWANG PHARMACEUTICAL IND CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Mezzion Pharma Co., Ltd. Develops and out-licenses novel therapeutics like udenafil, with a focus on rare diseases.	South Korea	140410
MFC Co., Ltd. A GMP-certified CDMO/CMO developing and manufacturing APIs for the global pharma sector.	South Korea	432980
Mithra Pharmaceuticals S.A. Biotech firm developing pharma for women's health: contraception, fertility, and menopause.	Belgium	MITRA
MIZUHO MEDY CO.,LTD. Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.	Japan	4595
MOA Life Plus Co. Ltd. Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.	South Korea	142760
Moberg Pharma Develops & commercializes a leading topical treatment for nail fungus for European markets.	Sweden	MOB
Mochida Pharmaceutical Co.,Ltd. An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.	Japan	4534
Moogene Medi Co., Ltd. Develops LNP drug delivery systems for severe diseases, offering R&D to GMP manufacturing support.	South Korea	322970
MORISHITA JINTAN CO.,LTD. Manufactures health products and provides OEM/ODM services using advanced encapsulation technology.	Japan	4524
MUROMACHI CHEMICALS INC. A diversified manufacturer of pharmaceuticals, chemical systems, health foods & functional materials.	Japan	4885